Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhengyuan Capsules for Cancer-related Fatigue in Breast Cancer
NCT06381557Phase 4Not yet recruiting
- Sponsor
- Qiangfu Biotech
- Start
- May 2024
- Primary completion
- Mar 2027
- Modality
- Botanical Extract
01
Overview
Phase 4, randomised, double-blind trial of Zhengyuan Capsule in cancer-related fatigue (CRF) (2 arms), sponsored by Qiangfu Biotech. Primary endpoint: Brief Fatigue Inventory at 8 weeks. Planned start May 2024; status: not yet recruiting.
02
Drugs
Zhengyuan Capsule
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT06381557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06381557.